Patents by Inventor Christopher T. Jacob

Christopher T. Jacob has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9775902
    Abstract: The present invention relates to methods and agents useful for the treatment of stroke, including ischemic stroke and hemorrhagic stroke. In particular, methods and agents for treating stroke in a subject are provided, wherein the agent is administered prior to diagnosis of the stroke as an ischemic stroke or a hemorrhagic stroke.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: October 3, 2017
    Assignee: FIBROGEN, INC
    Inventors: Stephen J. Klaus, Ingrid Langsetmo Parobok, Christopher T. Jacob
  • Publication number: 20120039882
    Abstract: The present invention relates to methods and agents for treating impaired vascular and cardiac function. Methods and agents for treating various physiological and pathological features associated with vascular dysfunction and cardiac dysfunction are also provided.
    Type: Application
    Filed: October 21, 2011
    Publication date: February 16, 2012
    Applicant: FibroGen, Inc.
    Inventors: Ingrid Langsetmo Parobok, Christopher T. Jacob, David Y. Liu
  • Patent number: 8088381
    Abstract: The present invention relates to methods for treating impaired cardiac function. Methods for treating various physiological and pathological features associated with cardiac dysfunction by administering an agent that inhibits the expression or activity of connective tissue growth factor (CTGF) are provided.
    Type: Grant
    Filed: May 5, 2006
    Date of Patent: January 3, 2012
    Assignee: FibroGen, Inc.
    Inventors: Ingrid Langsetmo Parobok, Christopher T. Jacob, David Y. Liu
  • Publication number: 20110263644
    Abstract: The present invention relates to methods and agents useful for the treatment of stroke, including ischemic stroke and hemorrhagic stroke. In particular, methods and agents for treating stroke in a subject are provided, wherein the agent is administered prior to diagnosis of the stroke as an ischemic stroke or a hemorrhagic stroke.
    Type: Application
    Filed: July 11, 2011
    Publication date: October 27, 2011
    Applicant: FibroGen, Inc.
    Inventors: Stephen J. Klaus, Ingrid Langsetmo Parobok, Christopher T. Jacob